Preparation and characterization of inclusion complexes of carvedilol with methyl-β-cyclodextrin

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 63, Issue 3-4, 2009, Pages 219-224

  Hirlekar, Rajashree ^a   Kadam, Vilasrao ^a  

^a BHARATI VIDYAPEETH S COLLEGE OF PHARMACY   (India)

Author keywords

Carvedilol; Characterization; Dissolution; Methyl cyclodextrin; Phase solubility studies

Indexed keywords

EID: 63049125218     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-008-9506-5     Document Type: Article

References (27)

1. Szejtli, J.: Cyclodextrin technology. Academic Publishers, Dordrecht (1988)
2. Z Wang Y Deng S Sun X Zhang 2006 Preparation of hydrophobic drug cyclodextrin complex by lyophilization monophase solution Drug Dev. Ind. Pharm. 32 73 83 10.1080/03639040500388359
3. HA Archontaki MV Vertzoni MH Athanassiou-Malaki 2002 Study on the inclusion complexes of bromazepam with β-and β-hydroxypropyl- cyclodextrins J. Pharm. Biomed. Anal. 28 761 769 10.1016/S0731-7085(01)00679-3
4. L Longxiao Z Suyan 2006 Preparation and characterization of inclusion complexes of prazosin hydrochloride with β-cyclodextrin and hydroxypropyl-β cyclodextrin J. Pharm. Biomed. Anal. 40 122 127 10.1016/j.jpba.2005.06.022
5. AR Hedges 1998 Industrial applications of cyclodextrins Chem. Rev. 98 2035 2044 10.1021/cr970014w
6. KA Connors 1997 The stability of cyclodextrin complexes in solution Chem. Rev. 97 1325 1357 10.1021/cr960371r
7. T Loftson ME Brewster 1996 Pharmaceutical applications of cyclodextrins.1 J. Pharm. Sci. 85 1017 1025 10.1021/js950534b
8. L Szente J Szejtli 1999 Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development Adv. Drug. Deliv. Rev. 36 17 28 10.1016/S0169-409X(98)00092-1
9. T Loftsson DS Peterson 1998 Cyclodextrin solubilization of ETH-615, a zwitterionic drug Drug Dev. Ind. Pharm. 24 365 370 10.3109/03639049809085632
10. Dollery, C.: Therapeutic drugs. Churchill Livingstone, United Kingdom (1999)
11. W Wen F Tan Z Jing L Ziuyang 2004 Preparation and study the 1:2 inclusion complex of carvedilol with β-cyclodextrin J. Pharm. Biomed. Anal. 34 517 523 10.1016/S0731-7085(03)00576-4
12. M Jug M Becirevic-Lacan 2004 Influence of hydroxypropyl-β- cyclodextrin complexation on piroxicam release from buccoadhesive tablets Eur. J. Pharm. Sci. 21 251 260 10.1016/j.ejps.2003.10.029
13. VR Sinha R Anitha S Ghosh Amita R Kumria JR Bhimge M Kumar 2007 Physicochemical characterization and in vitro dissolution behaviour of celecoxib-β-cyclodextrin inclusion complexes Acta. Pharm. 57 47 60 10.2478/v10007-007-0004-x
14. A Miro F Quaglia L Giannini B Cappello MIL Rotonda 2006 Drug/cyclodextrin solid systems in the design of hydrophilic matrices: a strategy to modulate drug delivery rate Curr. Drug. Deliv. 3 373 378 10.2174/156720106778558994
15. P Mura MT Faucci PL Parrini 2001 Effect of grinding with microcrystalline cellulose and cyclodextrins on the ketoprofen physicochemical properties Drug. Dev. Ind. Pharm. 27 119 128 10.1081/DDC-100000478
16. P Mura E Adragna A Rabasco J Moyano J Perez-Martinez M Arias J Gines 1999 Effects of the host cavity size and the preparation method on the physicochemical properties of Ibuproxam-cyclodextrin systems Drug. Dev. Ind. Pharm. 25 279 287 10.1081/DDC-100102172
17. LSS Ribeiro DC Ferrira FJB Veiga 2003 Physicochemical investigation of the effects of water soluble polymers on vinpocetine complexation with β-cyclodextrin and its sulfobutyl ether derivative in solution and solid state Eur. J. Pharm. Sci. 20 253 266 10.1016/S0928-0987(03)00199-4
18. LS Koester CR Xavier P Mayorga VL Bassani 2003 Influence of β-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose tablets Eur. J. Pharm. Sci. 55 85 91
19. CM Fernandes MT Vieira FJB Viega 2002 Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds Eur. J. Pharm. Sci. 15 79 88 10.1016/S0928-0987(01)00208-1
20. G Zingone F Rubessa 2005 Preformulation study of the inclusion complex warfarin-β-cyclodextrin Int. J. Pharm. 291 3 10 10.1016/j.ijpharm.2004.11. 013
21. LH Emara RM Badr AA Elbary 2002 Improving the dissolution and bioavailability of nifedipine using solid dispersions and solubilizers Drug. Dev. Ind. Pharm. 28 795 807 10.1081/DDC-120005625
22. K Dua MV Ramana UVS Sara M Himaja A Agarwal V Garg K Pabreja 2007 Investigation of enhancement of solubility of norfloxacin-β-cyclodextrin in presence of acidic solubilizing additives Curr. Drug. Deliv. 4 21 25 10.2174/156720107779314776
23. F Veiga C Fernandes P Maincent 2001 Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary systems Drug. Dev. Ind. Pharm. 27 523 532 10.1081/DDC-100105177
24. A Mukne M Nagarsenker 2004 Triamterene-β-cyclodextrin systems: preparation, characterization and in vivo evaluation AAPS PharmSciTech 5 1 9 10.1208/pt050119
25. A Saetern N Nguyen A Bauer-Brandl M Brandl 2004 Effect of hydroxypropyl-β-cyclodextrin-complexation and pH on the solubility of camptothecin Int. J. Pharm. 284 61 68 10.1016/j.ijpharm.2004.07.014
26. C Yanez R Salazar L Nunez-Vergara J Squella 2004 Spectrophotometric and electrochemical study of the inclusion complex between β-cyclodextrin and furnidipine J. Pharm. Biomed. Anal. 35 51 56 10.1016/j.jpba.2003.12.015
27. S Rawat S Jain 2004 Solubility enhancement of celecoxib using β-cyclodextrin inclusion complexes Eur. J. Pharm. Biopharm. 57 263 267 10.1016/j.ejpb.2003.10.020